Sophie Wang and Bryana McGillycuddy Named 2024 Rising IP Stars

Managing IP has recognized Sophie F. Wang and Bryana T. McGillycuddy as 2024 Rising IP Stars.

Sophie represents biotech, pharmaceutical, and technology companies in complex and high stakes intellectual property and commercial disputes across the country. She is a go-to resource for clients in the life sciences industry, including for complex patent litigation (including Hatch-Waxman and biosimilar litigation), post-grant review (PGR) and inter partes review (IPR) proceedings before the United States Patent Trial and Appeal Board (PTAB), trade secrets litigation, and contract, licensing, and other commercial disputes. Sophie also routinely advises clients on the management of their US and global patent and litigation strategies, including regularly consulting with counsel before the EPO and in the UK, Germany, and other foreign jurisdictions.

Bryana helps biotech, pharmaceutical, life sciences, and technology companies to successfully and efficiently resolve intellectual property-related disputes, including complex patent and trade secrets litigation. Her work includes Hatch-Waxman and biosimilars litigation, as well as post grant reviews before the USPTO. Bryana also advises clients through intellectual property counseling and conducting due diligence generally. In addition, Bryana has extensive experience representing clients in complex commercial disputes, including licensing disputes.

IP Stars research, rankings, and analysis provides independent and impartial accreditation in over 125 jurisdictions, including 1,850 firms and 5,700 practitioners. Each year, Managing IP’s research analysts in London, New York and Hong Kong obtain information from thousands of firms, IP practitioners and their clients through interviews, emails and online surveys.